Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Tenaya inspires investors for $92m series B
GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.
Icosavax applies $51m series A
Icosavax has launched out of University of Washington with $51m in series A funding to move a vaccine for respiratory syncytial virus into a phase 1b trial.
Kandou connects to $56m series C
EPFL spinout Kandou has pushed its total funding to $96m following a series C round that featured Swisscom Ventures and its Digital Transformation Fund.
Federated Wireless connects to $51m series C
The telecommunications spectrum provider has now raised $120m altogether, SBA Communications and American Tower contributing to its latest round.
Gyroscope spins to series B round
Gyroscope Therapeutics, a dry AMD treatment developer exploiting University of Cambridge research, has secured $61.2m from cornerstone investors Cambridge Innovation Capital and Syncona.
CSAA meets Kin in $47m round
UChicago Startup Investment Program is among a group of backers that provided $47m to support the launch of a Florida-focused home insurance carrier, the first of Kin's subsidiaries to underwrite its own policies.
Ethos sets its mind to $60m
GV was among the investors for Stanford-backed online life insurance provider Ethos's latest round, which brought the its total funding to more than $106m.
Form Energy sparks $40m
MIT grid battery spinout Form Energy has secured capital from investors including The Engine and Eni to bring its funding haul to nearly $50m.

Other News

Starship takes flight with $40m
Kyushu University's Qu Ventures has supported a series A round for robot-equipped consumer goods delivery service Starship Technologies.
Landos lands $60m
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
Carisma dazzles with extended series A
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
HawkEye 360 beams in $70m
Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.
Alizé Pharma 3 leads corporates to series A
Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.
Synspective secures series A funding
UTokyo IPC, Keio Innovation Initiative and Innovations and Future Creation have contributed to a $79.7m series A that increased the Tokyo spinout's total funding to about $100m.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Big deal: Touchstone helps inject $73m into Cell Medica
Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.
test reg